Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFFIRM: Fisetin for Frailty and Inflammation in Older Women
NCT03430037Phase 2Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Feb 2018
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in frailty syndrome, sponsored by Mayo Clinic. Started Feb 2018; status: enrolling by invitation.
02
Drugs
fisetin
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT03430037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430037.